Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Platelet dysfunction caused by aspirin (disorder) |
Causative agent |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Oesophageal ulcer caused by aspirin |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
astma forårsaget af overfølsomhed over for acetylsalicylsyre med nasale polypper |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin burn of oral mucosa |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Non-allergic anaphylaxis caused by aspirin |
Causative agent |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin-induced angioedema-urticaria (disorder) |
Causative agent |
True |
Aspirin (substance) |
Inferred relationship |
Some |
2 |
Intentional aspirin overdose |
Causative agent |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Salicylate blood measurement |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Serum salicylate measurement |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Administration of prophylactic aspirin for ischemic heart disease (procedure) |
Direct substance |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Acetylsalicylic acid measurement, qualitative |
Component |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Accidental aspirin poisoning |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Intentional aspirin poisoning |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
forgiftning med acetylsalicylsyre, uvist med hvilken hensigt |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Aspirin adverse reaction |
Causative agent |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Allergy to aspirin |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin overdose |
Causative agent |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Accidental aspirin overdose |
Causative agent |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
overdosis af acetylsalicylsyre, uvist med hvilken hensigt |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Administration of prophylactic aspirin |
Direct substance |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Plasma salicylate measurement |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 75 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 75 mg opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 300 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 300 mg opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 150 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 500 mg opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin/paracetamol/codeine tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 400 mg + codein 8 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
aspirin 500 mg + papaveretum 7,71 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin+papaveretum 500mg/10mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 300 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
ulcus oesophagi forårsaget af indtagelse af acetylsalicylsyre |
Causative agent |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Co-codaprin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 500 mg and glycine 133 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin+codeine 300mg/8mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing aspirin in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
kombinationspræparat med acetylsalicylsyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing aspirin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Some |
1 |
Salicylate measurement |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 81 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre tyggegummi 227,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 81 mg enterotablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 165 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 325 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 650 mg enterotablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 975 mg enterotablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 650 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 800 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 81 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 120 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 600 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 975 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and carisoprodol 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and meprobamate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre + pentazocinhydrochlorid 325 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre 975 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspirin 500 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
acetylsalicylsyre + caffein + orphenadrincitrat tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Ecotrin 325mg e/c tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Regular strength bayer enteric coated 325mg caplet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Genuine bayer aspirin 325mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Empirin 325mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Genprin 325mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Ecotrin maximum strength 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Extra strength bayer enteric 500 aspirin 500mg e/c tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Arthritis foundation pain reliever 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Maximum bayer aspirin 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Norwich extra strength 500mg tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Extended release bayer 8 hour 650mg er tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Ecotrin adult low strength 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Halfprin 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Heartline 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
1/2 Halfprin 165mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Bayer low adult strength 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Bayer children's aspirin 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
St. Joseph adult chewable aspirin 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|
Aspergum 227.5mg gum tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Some |
|